Creo Medical Group (LSE:CREO) EV-to-Revenue : 3.81 (As of May. 27, 2024)

View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Creo Medical Group's enterprise value is £117.22 Mil. Creo Medical Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £30.80 Mil. Therefore, Creo Medical Group's EV-to-Revenue for today is 3.81.

The historical rank and industry rank for Creo Medical Group's EV-to-Revenue or its related term are showing as below:

LSE:CREO' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.34 Med: 3.52 Max: 33.51
Current: 3.81

During the past 9 years, the highest EV-to-Revenue of Creo Medical Group was 33.51. The lowest was 0.34. And the median was 3.52.

LSE:CREO's EV-to-Revenue is ranked worse than
55.96% of 831 companies
in the Medical Devices & Instruments industry
Industry Median: 3.24 vs LSE:CREO: 3.81

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-27), Creo Medical Group's stock price is £0.3525. Creo Medical Group's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was £0.10. Therefore, Creo Medical Group's PS Ratio for today is 3.49.

Creo Medical Group EV-to-Revenue Historical Data

The historical data trend for Creo Medical Group's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group EV-to-Revenue Chart

Creo Medical Group Annual Data

Trend

Feb14

Feb15

Feb16

Jun17

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

14,758.15

29.01

9.41

1.63

5.06

Creo Medical Group Semi-Annual Data
	Feb14	Feb15	Feb16	Dec16	Jun17	Dec17	Jun18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial												9.41	-	1.63	-	5.06

Competitive Comparison of Creo Medical Group's EV-to-Revenue

For the Medical Devices subindustry, Creo Medical Group's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Creo Medical Group's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's EV-to-Revenue falls into.

Creo Medical Group EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Creo Medical Group's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	117.220	/	30.8
	=	3.81

Creo Medical Group's current Enterprise Value is £117.22 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Creo Medical Group's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was £30.80 Mil.

Creo Medical Group (LSE:CREO) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Creo Medical Group's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	0.3525	/	0.101
	=	3.49

Creo Medical Group's share price for today is £0.3525.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was £0.10.

Creo Medical Group EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Creo Medical Group (LSE:CREO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (LSE:CREO) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH

Website

https://www.creomedical.com

Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.

Creo Medical Group (LSE:CREO) Headlines

No Headlines